 Janelle Noel-MacDonnell
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DiGeorge Syndrome | 2 | 2022 | 4 | 1.160 |
Why?
| | Hypocalcemia | 1 | 2022 | 4 | 0.930 |
Why?
| | Humans | 33 | 2023 | 6257 | 0.810 |
Why?
| | Bronchopulmonary Dysplasia | 4 | 2022 | 41 | 0.750 |
Why?
| | Tracheostomy | 4 | 2022 | 11 | 0.680 |
Why?
| | Models, Genetic | 1 | 2018 | 18 | 0.670 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 16 | 0.670 |
Why?
| | Retrospective Studies | 15 | 2022 | 1232 | 0.670 |
Why?
| | Female | 16 | 2023 | 3322 | 0.500 |
Why?
| | Substance-Related Disorders | 2 | 2023 | 33 | 0.430 |
Why?
| | Lung Diseases | 2 | 2021 | 26 | 0.400 |
Why?
| | Genetic Testing | 2 | 2021 | 74 | 0.380 |
Why?
| | Child | 10 | 2022 | 3020 | 0.370 |
Why?
| | Lung | 2 | 2020 | 76 | 0.370 |
Why?
| | Infant, Newborn | 9 | 2022 | 811 | 0.360 |
Why?
| | Male | 12 | 2021 | 3210 | 0.320 |
Why?
| | Risk Factors | 7 | 2021 | 394 | 0.300 |
Why?
| | Contraception | 2 | 2023 | 33 | 0.290 |
Why?
| | Infant | 8 | 2022 | 1392 | 0.280 |
Why?
| | Respiration, Artificial | 2 | 2022 | 16 | 0.260 |
Why?
| | Cluster Analysis | 3 | 2019 | 29 | 0.260 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 5 | 0.240 |
Why?
| | Intrauterine Devices | 1 | 2023 | 4 | 0.240 |
Why?
| | Electronic Health Records | 2 | 2021 | 59 | 0.240 |
Why?
| | Transcriptome | 2 | 2022 | 40 | 0.230 |
Why?
| | Health Education | 1 | 2023 | 39 | 0.230 |
Why?
| | Lymphopenia | 1 | 2022 | 1 | 0.230 |
Why?
| | Risk Assessment | 2 | 2020 | 129 | 0.230 |
Why?
| | Calcium | 1 | 2022 | 46 | 0.230 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 23 | 0.230 |
Why?
| | Rhinitis | 1 | 2022 | 3 | 0.220 |
Why?
| | Sinusitis | 1 | 2022 | 6 | 0.220 |
Why?
| | Mediastinal Neoplasms | 1 | 2021 | 4 | 0.220 |
Why?
| | Anesthesia | 1 | 2021 | 4 | 0.220 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 7 | 0.220 |
Why?
| | Kidney Transplantation | 1 | 2022 | 107 | 0.210 |
Why?
| | Nose Diseases | 1 | 2021 | 1 | 0.210 |
Why?
| | Velopharyngeal Insufficiency | 1 | 2021 | 1 | 0.210 |
Why?
| | Voice Disorders | 1 | 2021 | 1 | 0.210 |
Why?
| | Genetic Association Studies | 1 | 2021 | 31 | 0.210 |
Why?
| | Cleft Palate | 1 | 2021 | 8 | 0.210 |
Why?
| | Atrial Flutter | 1 | 2021 | 1 | 0.210 |
Why?
| | Leukemia | 1 | 2021 | 15 | 0.210 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2022 | 70 | 0.210 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2021 | 19 | 0.210 |
Why?
| | Neurotoxins | 1 | 2021 | 4 | 0.210 |
Why?
| | Ear, Inner | 1 | 2020 | 1 | 0.210 |
Why?
| | Labyrinth Diseases | 1 | 2020 | 1 | 0.210 |
Why?
| | Temporal Bone | 1 | 2020 | 1 | 0.210 |
Why?
| | Anatomic Variation | 1 | 2020 | 1 | 0.210 |
Why?
| | Hearing Loss | 1 | 2020 | 4 | 0.200 |
Why?
| | Diverticulum | 1 | 2020 | 4 | 0.200 |
Why?
| | Botulinum Toxins | 1 | 2021 | 6 | 0.200 |
Why?
| | Adult | 5 | 2023 | 1128 | 0.200 |
Why?
| | Environment Design | 1 | 2021 | 16 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 142 | 0.200 |
Why?
| | Child Development | 1 | 2020 | 42 | 0.190 |
Why?
| | Enterocolitis | 1 | 2021 | 35 | 0.190 |
Why?
| | Neonatal Nursing | 1 | 2020 | 2 | 0.190 |
Why?
| | Chorioamnionitis | 1 | 2020 | 4 | 0.190 |
Why?
| | Echocardiography | 1 | 2020 | 58 | 0.190 |
Why?
| | Hirschsprung Disease | 1 | 2021 | 57 | 0.190 |
Why?
| | Language Development | 1 | 2019 | 3 | 0.190 |
Why?
| | Conscious Sedation | 1 | 2019 | 1 | 0.190 |
Why?
| | Simulation Training | 1 | 2019 | 1 | 0.190 |
Why?
| | Waiting Lists | 1 | 2019 | 12 | 0.190 |
Why?
| | Professional-Family Relations | 1 | 2019 | 8 | 0.190 |
Why?
| | Neonatology | 1 | 2019 | 6 | 0.190 |
Why?
| | Cognition | 1 | 2019 | 30 | 0.190 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 11 | 0.190 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2019 | 3 | 0.190 |
Why?
| | Appointments and Schedules | 1 | 2019 | 13 | 0.190 |
Why?
| | Toll-Like Receptor 4 | 1 | 2019 | 13 | 0.180 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 96 | 0.180 |
Why?
| | Postoperative Complications | 1 | 2021 | 181 | 0.180 |
Why?
| | Heart Defects, Congenital | 1 | 2020 | 74 | 0.180 |
Why?
| | Crowdsourcing | 1 | 2019 | 1 | 0.180 |
Why?
| | Communication | 1 | 2019 | 51 | 0.180 |
Why?
| | Normal Distribution | 1 | 2018 | 2 | 0.180 |
Why?
| | Models, Statistical | 1 | 2018 | 24 | 0.180 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 81 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 113 | 0.170 |
Why?
| | Lipoprotein(a) | 1 | 2018 | 1 | 0.170 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 8 | 0.170 |
Why?
| | Likelihood Functions | 1 | 2018 | 5 | 0.170 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 12 | 0.170 |
Why?
| | Parents | 1 | 2019 | 141 | 0.170 |
Why?
| | Health Behavior | 1 | 2018 | 69 | 0.160 |
Why?
| | Child, Preschool | 5 | 2020 | 1474 | 0.160 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 49 | 0.160 |
Why?
| | Patient Readmission | 1 | 2018 | 66 | 0.160 |
Why?
| | Patient Compliance | 1 | 2018 | 71 | 0.160 |
Why?
| | Respiratory Tract Infections | 1 | 2018 | 72 | 0.150 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 245 | 0.150 |
Why?
| | Myositis, Inclusion Body | 1 | 2016 | 1 | 0.150 |
Why?
| | Homeostasis | 1 | 2016 | 9 | 0.150 |
Why?
| | Proteins | 1 | 2016 | 20 | 0.150 |
Why?
| | Pediatric Obesity | 1 | 2018 | 120 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 3 | 2021 | 33 | 0.140 |
Why?
| | Infant, Premature | 3 | 2022 | 84 | 0.140 |
Why?
| | Adolescent | 4 | 2023 | 2029 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2021 | 622 | 0.120 |
Why?
| | Pregnancy | 2 | 2023 | 255 | 0.100 |
Why?
| | Young Adult | 2 | 2023 | 610 | 0.100 |
Why?
| | Age Factors | 2 | 2020 | 213 | 0.100 |
Why?
| | Gestational Age | 2 | 2020 | 66 | 0.090 |
Why?
| | Cohort Studies | 2 | 2021 | 256 | 0.090 |
Why?
| | Patient Discharge | 2 | 2021 | 59 | 0.090 |
Why?
| | Time Factors | 2 | 2020 | 258 | 0.090 |
Why?
| | Databases, Factual | 2 | 2019 | 102 | 0.080 |
Why?
| | Mutation | 2 | 2021 | 209 | 0.080 |
Why?
| | Clinical Trials as Topic | 2 | 2019 | 43 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 293 | 0.080 |
Why?
| | Mice | 2 | 2019 | 433 | 0.070 |
Why?
| | Animals | 2 | 2019 | 853 | 0.070 |
Why?
| | Pregnancy, Unplanned | 1 | 2023 | 9 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2023 | 61 | 0.060 |
Why?
| | Patient-Centered Care | 1 | 2023 | 17 | 0.060 |
Why?
| | Contraceptive Agents | 1 | 2023 | 14 | 0.060 |
Why?
| | Program Evaluation | 1 | 2023 | 52 | 0.060 |
Why?
| | Survival Rate | 1 | 2022 | 72 | 0.060 |
Why?
| | Retinoid X Receptors | 1 | 2022 | 4 | 0.060 |
Why?
| | Pilot Projects | 1 | 2023 | 123 | 0.060 |
Why?
| | Chromosomes | 1 | 2022 | 3 | 0.060 |
Why?
| | Systems Analysis | 1 | 2022 | 2 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2022 | 36 | 0.060 |
Why?
| | Health Expenditures | 1 | 2022 | 15 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2022 | 36 | 0.060 |
Why?
| | Enteral Nutrition | 1 | 2022 | 55 | 0.060 |
Why?
| | Fungi | 1 | 2022 | 20 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 1 | 0.050 |
Why?
| | Karyotyping | 1 | 2021 | 9 | 0.050 |
Why?
| | Medication Adherence | 1 | 2022 | 57 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 9 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2022 | 130 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 34 | 0.050 |
Why?
| | Palate, Soft | 1 | 2021 | 1 | 0.050 |
Why?
| | Length of Stay | 1 | 2022 | 234 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2021 | 2 | 0.050 |
Why?
| | Standard of Care | 1 | 2021 | 5 | 0.050 |
Why?
| | Cities | 1 | 2021 | 10 | 0.050 |
Why?
| | Kansas | 1 | 2021 | 49 | 0.050 |
Why?
| | Audiometry | 1 | 2020 | 1 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 90 | 0.050 |
Why?
| | Phenotype | 1 | 2021 | 221 | 0.050 |
Why?
| | Recovery of Function | 1 | 2020 | 16 | 0.050 |
Why?
| | Infant, Extremely Premature | 1 | 2020 | 13 | 0.050 |
Why?
| | Incidence | 1 | 2021 | 129 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2021 | 121 | 0.050 |
Why?
| | Chronic Disease | 1 | 2021 | 106 | 0.050 |
Why?
| | Walking | 1 | 2021 | 35 | 0.050 |
Why?
| | Alleles | 1 | 2021 | 163 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2021 | 42 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2020 | 8 | 0.050 |
Why?
| | Weight Gain | 1 | 2020 | 23 | 0.050 |
Why?
| | Genotype | 1 | 2021 | 299 | 0.050 |
Why?
| | Pandemics | 1 | 2021 | 76 | 0.050 |
Why?
| | Prevalence | 1 | 2020 | 141 | 0.050 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 178 | 0.050 |
Why?
| | Digestive System Surgical Procedures | 1 | 2021 | 45 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 124 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2020 | 33 | 0.050 |
Why?
| | Language Development Disorders | 1 | 2019 | 3 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2019 | 13 | 0.050 |
Why?
| | Self-Assessment | 1 | 2019 | 5 | 0.050 |
Why?
| | Professional Competence | 1 | 2019 | 3 | 0.050 |
Why?
| | Attitude | 1 | 2019 | 14 | 0.050 |
Why?
| | Curriculum | 1 | 2019 | 20 | 0.050 |
Why?
| | Exercise | 1 | 2021 | 114 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 19 | 0.050 |
Why?
| | Family | 1 | 2019 | 26 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2019 | 16 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2019 | 32 | 0.050 |
Why?
| | Cytokines | 1 | 2019 | 48 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 21 | 0.050 |
Why?
| | Ireland | 1 | 2019 | 1 | 0.050 |
Why?
| | Italy | 1 | 2019 | 3 | 0.050 |
Why?
| | Organizations, Nonprofit | 1 | 2019 | 3 | 0.050 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2019 | 3 | 0.050 |
Why?
| | Pneumonia | 1 | 2019 | 31 | 0.050 |
Why?
| | Machine Learning | 1 | 2019 | 14 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 140 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 41 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 7 | 0.040 |
Why?
| | Atherosclerosis | 1 | 2018 | 2 | 0.040 |
Why?
| | Pulse Wave Analysis | 1 | 2018 | 4 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2018 | 1 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 6 | 0.040 |
Why?
| | Oxygen | 1 | 2018 | 16 | 0.040 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 10 | 0.040 |
Why?
| | Signal Transduction | 1 | 2019 | 146 | 0.040 |
Why?
| | Self Report | 1 | 2018 | 40 | 0.040 |
Why?
| | Algorithms | 1 | 2019 | 94 | 0.040 |
Why?
| | Dyslipidemias | 1 | 2018 | 14 | 0.040 |
Why?
| | Logistic Models | 1 | 2018 | 79 | 0.040 |
Why?
| | Primary Health Care | 1 | 2018 | 43 | 0.040 |
Why?
| | Missouri | 1 | 2018 | 78 | 0.040 |
Why?
| | Hypertension | 1 | 2018 | 57 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 288 | 0.040 |
Why?
| | United States | 1 | 2020 | 630 | 0.040 |
Why?
| | Hydroxylamines | 1 | 2016 | 1 | 0.040 |
Why?
| | Myoblasts | 1 | 2016 | 2 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2016 | 3 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2016 | 2 | 0.040 |
Why?
| | Muscle Strength | 1 | 2016 | 3 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2016 | 3 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 3 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2016 | 7 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.040 |
Why?
| | Cell Survival | 1 | 2016 | 18 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 13 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2016 | 111 | 0.040 |
Why?
| | Rats | 1 | 2016 | 193 | 0.040 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|